MKP11093 has shown strong results in preclinical studies with a promising safety and selectivity profile
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
Replicate will receive research funding and could potentially receive up to approximately US$550 million
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
Triggering global regulatory submissions this year for the treatment of obesity
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
Attorney General Ken Paxton sued pharmaceutical giant Eli Lilly for bribing and illegally inducing medical providers to prescribe its most profitable drugs
Pfizer's vaccine helps protect against clinically relevant 20 serotypes responsible for a majority of invasive and non-invasive pneumococcal disease
AINU is set to accelerate its expansion footprint, enhance operational capabilities
Glucagon is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
